INSIGHTS ON DRUG DEVELOPMENT

• Where Speed Meets Complexity In Bioprocess Development

  Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.

• Engineering The Future Of Lipsomal Drug Delivery

  Explore our full collection of case studies to discover how liposome technology is transforming drug delivery across a wide range of therapies.

• Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines

  Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.

• Producing Quality APIs At Scale

  Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.

• Expanding The OSD Toolbox: An Industry Approach To Adsorb Lipids Onto Powder Substrates

  12/11/2024

  Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.

• Cell Culture Media Filtration: Evaluating Cell Culture Performance

  10/23/2025

  Cell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.

• Ready To Demystify Organoids?

  7/1/2025

  Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.

• Development Of A Non-Standard Protein Therapeutic

  2/4/2026

  Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.

• Integrating Phase-Appropriate Quality Standards

  12/9/2024

  Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.